LABCORP HOLDINGS INC. — Director's Dealing 2016

Apr 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2016-03-30

Reporting Person: Boyle James T. Jr. (EVP,CEO of LabCorp Diagnostics)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-30	Common Stock	A	34737	—	Acquired	58191	Direct
2016-03-30	Common Stock	F	16605	$117.85	Disposed	41586	Direct
2016-03-31	Common Stock	S	13191	$116.67	Disposed	28395	Direct
2016-03-31	Common Stock	S	4941	$117.19	Disposed	23454	Direct

Footnotes

F1: Shares acquired on March 30, 2016, pursuant to a performance award granted on February 12, 2013, relating to performance during the three-year period ended December 31, 2015.

F2: Stock withholding to satisfy tax withholding obligations.

F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F4: The price of $116.67 per share represents a weighted average of sales prices ranging from $116.10 to $117.09 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

F5: The price of $117.19 per share represents a weighted average of sales prices ranging from $117.10 to $117.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.